Trial intelligence / Profile preview

Prasugrel vs Clopidogrel in Asian ACS Patients Undergoing PCI

NCT00830960Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Feb 2009
Primary completion
Jun 2010
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of prasugrel in acute coronary syndrome (ACS), sponsored by Eli Lilly and Company. Started Feb 2009; status: completed.

02

Drugs

prasugrel
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT00830960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00830960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call